Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome

  title={Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome},
  author={LouJin Song and Seon-hye E. Park and Yehuda Isseroff and Kumi Morikawa and Masayuki Yazawa},
  journal={Stem Cell Reports},
  pages={50 - 57}

Figures from this paper

Highlight article: Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside

A detailed review of Timothy syndrome is provided, the mechanisms underlying dysfunctional Cav1.2 due to CACNA1C mutations are discussed, and some new emerging evidences in treating Timothy syndrome from cell to bedside are provided, promoting the management of this rare disease.

Timothy syndrome iPSC modeling

Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome

It is reported that pharmacological targeting of sigma non-opioid intracellular receptor 1 (SIGMAR1) can restore electrophysiological function in iPSC-derived cardiomyocytes generated from patients with Timothy syndrome and two common forms of long QT syndrome.

Update on the Molecular Genetics of Timothy Syndrome

Multiple possible mechanisms for the variability seen in clinical features across TS cases are discussed, including mosaicism, genetic background, isoform complexity of CACNA1C and differential expression of transcripts, and biophysical changes in mutant CAC NA1C channels.

LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway

Together, these studies identify LncHrt as a cardiac metabolic regulator that plays an essential role in preserving heart function by regulating downstream metabolic signaling pathways and is a potentially novel RNA-based therapeutic target for ischemic heart disease.

Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists

The role of the various ion channels in cardiac electrophysiology and the molecular and cellular mechanisms of arrhythmias are discussed, highlighting the promise of human induced pluripotent stem cells as a model for investigating inherited arrhythmia syndromes and testing antiarrhythmic strategies.

Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies

  • J. Striessnig
  • Biology, Medicine
    Frontiers in Synaptic Neuroscience
  • 2021
This review summarizes the current knowledge of human disease-relevant genetic variants within the family of voltage gated Ca2+ channels and focuses on the rapidly increasing number of de novo missense mutations identified in the pore-forming α1-subunits with next generation sequencing studies of well-defined patient cohorts.

Towards Mutation-Specific Precision Medicine in Atypical Clinical Phenotypes of Inherited Arrhythmia Syndromes

Since the epileptic phenotype appears to manifest prior to cardiac events in this mutation carrier, identifying KCND3 mutations in patients with epilepsy and providing optimal therapy will help prevent sudden unexpected death in epilepsy.

CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation

CDK5 positively regulates Notch1 function via phosphorylation, which in turn promotes cell proliferation and migration, and the combinational inhibition of CDK5 and Notch signaling may be an effective strategy in the treatment of PDAC.

Precision Medicine and cardiac channelopathies: when dreams meet reality

This work has explored the main layers that should be considered when developing a PM approach for cardiac channelopathies, with a focus on modern in vitro strategies based on patient-specific human-induced pluripotent stem cells and on in silico models.



Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca2+-dependent inactivation

A significant defect in CDI in TS channels is found, and a remarkable divergence in the underlying mechanism for G406R versus G402S variants is uncovered, suggesting an important therapeutic principle: a small shift in the complement of mutant versus wild-type channels may confer significant clinical improvement.

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome

Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia. LQTS is commonly genetic in origin but can

The Timothy syndrome mutation of cardiac CaV1.2 (L‐type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation

The mathematical model showed that slowed deactivation plus impaired OSvdI combine to synergistically increase cardiac action potential duration that is a likely cause of arrhythmias in TS patients and inactivation‐enhancing drugs are likely to improve cardiac arrh rhythmias and other pathologies afflicting TS patients.

Novel Timothy syndrome mutation leading to increase in CACNA1C window current.

Roscovitine Binds to Novel L-channel (CaV1.2) Sites That Separately Affect Activation and Inactivation*

It is concluded that (R)-roscovitine binds to distinct sites on L-type channels to slow activation and enhance inactivation, which appear to be unique from other calcium channel antagonist sites that reside within domains III and IV and are thus novel sites that could be exploited for future drug development.

A case of Timothy syndrome with adrenal medullary dystrophy

This is the first report describing a systemic autopsy of TS with adrenal medullary dystrophy, and suggests that CACNA1C mutation may induce drop‐out of medulla cells via apoptosis.

Modelling the long QT syndrome with induced pluripotent stem cells

The ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents represents a promising paradigm to study disease mechanisms, optimize patient care, and aid in the development of new therapies.

Cdk5 activity in the brain – multiple paths of regulation

Specific modulation of these protein regulators is expected to provide alternative strategies for the development of effective therapeutic interventions that are triggered by deregulation of Cdk5, including several recently identified protein activators and inhibitors that control its activity in normal and diseased brains.

Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann–Pick Type C Murine Model

The data suggest that focal deregulation of cyclin-dependent kinase 5/p25 in axons leads to cytoskeletal abnormalities and eventual neurodegeneration in NPC, and the npc-1 mouse is a valuablein vivo model for determining how and when cdk5 becomes deregulated and whethercdk5 inhibitors would be useful in blocking NPC neurodegenersation.